Stuart J. Schnitt

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• World Health Organization classification of tumours of the breast 6th edition 2026

  Histopathology · 2026-04-21

• Abstract 3434: Spatially resolved multi-omic profiling reveals BRCA-dependent immune remodeling during PARP inhibition and PD-L1 blockade

  Cancer Research · 2026-04-03

• Abstract 7903: MiR-362-3p enhances platinum response in breast cancer

  Cancer Research · 2026-04-03

• The miR-362-3p/ <i>BCLAF1</i> axis regulates cisplatin sensitivity and metastatic progression in triple-negative breast cancer

  medRxiv · 2026-03-10

• Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer

  npj Breast Cancer · 2026-02-13

• A Validation Study of an Expanded Description of Glandular (Acinar)/Tubule Formation for the Use of Nottingham Grading System for Invasive Breast Carcinomas Demonstrates Improvement in Concordance for Breast Pathologists and Trainees in Pathology

  Archives of Pathology & Laboratory Medicine · 2025-11-04

• 1270 APOE tumor-associated macrophages and CD4-DOCK4 T cells reveal distinct microenvironmental features in HER2-Low and HER2–0 hormone receptor-positive breast cancer

  Regular and Young Investigator Award Abstracts · 2025-11-01

• International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories

  Modern Pathology · 2025-10-28 · 14 citations

• Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

  JNCI Journal of the National Cancer Institute · 2025-10-08

• APOE+ Tumor-Associated Macrophages and CD4-DOCK4 T Cells Reveal Distinct Microenvironmental Features in HER2-Low and HER2-0 Hormone Receptor-Positive Breast CancerPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-09-09 · 1 citations

• Breast myoepithelial markers: Problems and pitfalls for the practicing pathologist

  Human Pathology · 2025-08-01 · 1 citations

• Clinical challenges and proposed solutions for patients with invasive lobular breast cancer

  Annals of Oncology · 2025-07-21 · 6 citations

• Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast

  Modern Pathology · 2025-07-03 · 2 citations

• Abstract P2-01-20: Impact of Exercise on Immune Biomarkers in Benign Breast Tissue from Women with High Mammographic Breast Density (MBD)

  Clinical Cancer Research · 2025-06-13

• Abstract GS2-05: Early Oncologic Outcomes Following Active Monitoring or Surgery (+/- Radiation) for Low Risk DCIS: the Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET) Study (AFT-25)

  Clinical Cancer Research · 2025-06-13 · 1 citations

• Abstract P1-07-03: Improved Standardization and Accuracy of HER2 Score with AI support in Breast Cancer: Large Multicenter Study

  Clinical Cancer Research · 2025-06-13

• In response to “Classification of Invasive Lobular Carcinoma”

  Modern Pathology · 2025-06-01

• Automated prediction of response to neoadjuvant chemotherapy from digitized H&amp;E slides of pre-treatment core needle biopsies in INFORM (TBCRC 031) patients with low stromal TILs.

  Journal of Clinical Oncology · 2025-05-28

• Supplementary Protocol S1 from A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast CancerPreprint

  2025-05-13

• Data from A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast CancerPreprint

  2025-05-13